Illumina, Inc.

Nasdaq ILMN · San Diego, CA

Works in Genetic & rare · Renal & urogenital · Women's health

Illumina, Inc. is a clinical trial sponsor based in San Diego, CA, listed as Nasdaq ILMN. It has no active clinical trials as lead sponsor; its trials since 2021 were in Genetic & rare, Renal & urogenital and Women's health. Since 2021 it has completed 5 trials and stopped 0 early. Its FDA record on file shows 1 recall.

Trial track record · since 2021

0Active trials0 planned participants
5Completed0 with results posted
0Stopped early0% of finished trials

FDA record

0InspectionsNone posted since 2025
0Warning lettersNone on file
1RecallLatest 2026-10-07: Class II

Recent FDA actions

Financials · Nasdaq ILMN

Cash and equivalents
R&D expense
Net income (loss)
Cash runway

Pipeline · 0 active trials

No active trials with this company as lead sponsor.

Questions about Illumina, Inc

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2024-05-01.

The FDA record counts inspection classifications, warning letters and recalls FDA has published that name this company. Compare it with the industry in the free CDMO FDA inspection lookup.

Approve Suite is not affiliated with Illumina, Inc..

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.